Company news
Theravance Biopharma, Inc. news in 2020
Theravance Biopharma, Inc.'s news releases, calls and decks from 2020, newest first.
Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference
November 16, 2020
Theravance Biopharma, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
November 4, 2020
Theravance Biopharma to Report Third Quarter 2020 Financial Results on November 5, 2020
October 21, 2020
Theravance Biopharma, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
August 5, 2020
Theravance Biopharma to Report Second Quarter 2020 Financial Results on August 6, 2020
July 26, 2020
Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors
July 1, 2020
Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-0903 for the Treatment of Hospitalized Patients with Acute Lung Injury Caused by COVID-19
June 24, 2020
Theravance Biopharma, Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
May 5, 2020
Theravance Biopharma to Report First Quarter 2020 Financial Results on May 6, 2020
April 27, 2020
Theravance Biopharma Announces First Subject Dosed in Phase 1 Study of TD-0903, in Development for the Treatment of Hospitalized Patients with Acute Lung Injury Caused by COVID-19
April 22, 2020
Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis
April 19, 2020
Theravance Biopharma Responds to COVID-19 Pandemic by Advancing TD-0903 to Treat Hospitalized Patients with Acute Lung Injury
April 8, 2020
Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes
March 1, 2020
Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
February 23, 2020
Theravance Biopharma Announces Presentations at Upcoming Investor Conferences
February 17, 2020
Theravance Biopharma to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020
February 12, 2020
Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares
February 10, 2020
Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares
February 9, 2020
Theravance Biopharma Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference
January 6, 2020
Decks in 2020
- Q3 2020 Earnings Presentation
Earnings · 40 slides · Nov 5, 2020
- Q3 2020 Earnings Presentation
Earnings · 25 slides · Nov 5, 2020
- Investor Presentation (September 2020)
Investor deck · 44 slides · Sep 14, 2020
- Q2 2020 Earnings Presentation
Earnings · 14 slides · Aug 6, 2020
- Q1 2020 Earnings Presentation
Earnings · 30 slides · May 6, 2020
- Corporate Update (April 2020)
Corporate update · 12 slides · Apr 9, 2020
- FY2019 Earnings Presentation
Earnings · 30 slides · Feb 24, 2020
- Investor Presentation (January 2020)
Investor deck · 34 slides · Jan 13, 2020